WCN24-2159 REAL-WORLD EVIDENCE REGARDING RENAL EFFECT OF MIGALASTAT
Saved in:
| Main Authors: | Sebastián Jaurretche, German Perez, Victoria Sgro, María Luana Brajkovic, María Victoria del Rosal, Graciela Venera |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S246802492400812X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Baseline Characteristics of Fabry Disease “Amenable” Migalastat Patients in Argentinian Cohort
by: Sebastián Jaurretche, et al.
Published: (2024-01-01) -
WCN24-2096 Fabry disease screening in male kidney transplant recipients. Two centers study from Argentina
by: Silvia Di Pietrantonio, et al.
Published: (2024-04-01) -
Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry disease
by: Malte Lenders, et al.
Published: (2025-02-01) -
Fabry nephropathy. Urinary expression of podocyte proteins mRNA and microRNAs in non-albuminuric patients
by: Sebastián Jaurretche, et al.
Published: (2024-07-01) -
Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report
by: Natalja Haninger-Vacariu, et al.
Published: (2019-01-01)